NVST Quote, Financials, Valuation and Earnings

Biolase has a net margin of 0.18% compared to Envista Holdings's net margin of -13.16%. Envista Holdings's return on equity of -32.33% beat Biolase's return on equity of -21668.17%.

Envista Holdings has a consensus price target of $21.33, signalling upside risk potential of 24.25%. On the other hand Biolase has an analysts' consensus of $1.2000 which suggests that it could grow by 24652.48%. Given that Biolase has higher upside potential than Envista Holdings, analysts believe Biolase is more attractive than Envista Holdings.

Envista Holdings has a beta of 1.326, which suggesting that the stock is 32.59% more volatile than S&P 500. In comparison Biolase has a beta of 0.817, suggesting its less volatile than the S&P 500 by 18.311%.

Envista Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Biolase offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Envista Holdings pays -- of its earnings as a dividend. Biolase pays out -- of its earnings as a dividend.

Envista Holdings quarterly revenues are $652.9M, which are larger than Biolase quarterly revenues of $10.9M. Envista Holdings's net income of $1.2M is higher than Biolase's net income of -$1.4M. Notably, Envista Holdings's price-to-earnings ratio is -- while Biolase's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Envista Holdings is 1.18x versus 0.00x for Biolase. Usually stocks with elevated PS ratios are considered overvalued.

Milestone Scientific has a net margin of 0.18% compared to Envista Holdings's net margin of -58.13%. Envista Holdings's return on equity of -32.33% beat Milestone Scientific's return on equity of -61.33%.

Envista Holdings has a consensus price target of $21.33, signalling upside risk potential of 24.25%. On the other hand Milestone Scientific has an analysts' consensus of -- which suggests that it could grow by 133.52%. Given that Milestone Scientific has higher upside potential than Envista Holdings, analysts believe Milestone Scientific is more attractive than Envista Holdings.

Envista Holdings has a beta of 1.326, which suggesting that the stock is 32.59% more volatile than S&P 500. In comparison Milestone Scientific has a beta of 1.409, suggesting its more volatile than the S&P 500 by 40.929%.

Envista Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Milestone Scientific offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Envista Holdings pays -- of its earnings as a dividend. Milestone Scientific pays out -- of its earnings as a dividend.

Envista Holdings quarterly revenues are $652.9M, which are larger than Milestone Scientific quarterly revenues of $2.5M. Envista Holdings's net income of $1.2M is higher than Milestone Scientific's net income of -$1.5M. Notably, Envista Holdings's price-to-earnings ratio is -- while Milestone Scientific's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Envista Holdings is 1.18x versus 8.04x for Milestone Scientific. Usually stocks with elevated PS ratios are considered overvalued.

Sonendo has a net margin of 0.18% compared to Envista Holdings's net margin of --. Envista Holdings's return on equity of -32.33% beat Sonendo's return on equity of --.

Envista Holdings has a consensus price target of $21.33, signalling upside risk potential of 24.25%. On the other hand Sonendo has an analysts' consensus of -- which suggests that it could fall by --. Given that Envista Holdings has higher upside potential than Sonendo, analysts believe Envista Holdings is more attractive than Sonendo.

Envista Holdings has a beta of 1.326, which suggesting that the stock is 32.59% more volatile than S&P 500. In comparison Sonendo has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Envista Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Sonendo offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Envista Holdings pays -- of its earnings as a dividend. Sonendo pays out -- of its earnings as a dividend.

Envista Holdings quarterly revenues are $652.9M, which are larger than Sonendo quarterly revenues of --. Envista Holdings's net income of $1.2M is higher than Sonendo's net income of --. Notably, Envista Holdings's price-to-earnings ratio is -- while Sonendo's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Envista Holdings is 1.18x versus -- for Sonendo. Usually stocks with elevated PS ratios are considered overvalued.

Dentsply Sirona has a net margin of 0.18% compared to Envista Holdings's net margin of -47.51%. Envista Holdings's return on equity of -32.33% beat Dentsply Sirona's return on equity of -32.39%.

Envista Holdings has a consensus price target of $21.33, signalling upside risk potential of 24.25%. On the other hand Dentsply Sirona has an analysts' consensus of $20.20 which suggests that it could grow by 28.54%. Given that Dentsply Sirona has higher upside potential than Envista Holdings, analysts believe Dentsply Sirona is more attractive than Envista Holdings.

Envista Holdings has a beta of 1.326, which suggesting that the stock is 32.59% more volatile than S&P 500. In comparison Dentsply Sirona has a beta of 0.976, suggesting its less volatile than the S&P 500 by 2.383%.

Envista Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Dentsply Sirona offers a yield of 4.11% to investors and pays a quarterly dividend of $0.16 per share. Envista Holdings pays -- of its earnings as a dividend. Dentsply Sirona pays out -13.85% of its earnings as a dividend.

Envista Holdings quarterly revenues are $652.9M, which are smaller than Dentsply Sirona quarterly revenues of $905M. Envista Holdings's net income of $1.2M is higher than Dentsply Sirona's net income of -$430M. Notably, Envista Holdings's price-to-earnings ratio is -- while Dentsply Sirona's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Envista Holdings is 1.18x versus 0.83x for Dentsply Sirona. Usually stocks with elevated PS ratios are considered overvalued.